Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis

Cancer Science

Volumn 102, Issue 11, 2011, Pages 1943-1948

  Uekita, Takamasa ^a   Sakai, Ryuichi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN CDCP1; UNCLASSIFIED DRUG;

CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANOIKIS; ANTIGENS, CD; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 80054982459     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02052.x     Document Type: Review

References (39)

1. Hanahan D, Weiberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
2. Kim LC, Song L, Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 2009; 6: 587-95.
3. Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T, Sakai R. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol 2007; 27: 7649-60.
4. Scherl-Mostageer M, Sommergruber W, Abseher R, Hauptmann R, Ambros P, Schweifer N. Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene 2001; 20: 4402-8.
5. Hooper JD, Zijlstra A, Aimes RT et al. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135kDa cell surface phosphorylated glycoprotein antigen. Oncogene 2003; 22: 1783-94.
6. Brown TA, Yang TM, Zaitsevskaia T et al. Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia. J Biol Chem 2004; 279: 14772-83.
7. Bhatt AS, Erdjument-Bromage H, Tempst P, Craik CS, Moasser MM. Adhesion signaling by a novel mitotic substrates of src kinases. Oncogene 2005; 24: 5333-43.
8. Xia Y, Gil SG, Carter W. Anchorage mediated by integrin α6β4 to laminin 5 (Epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kDa protein. J Cell Biol 1996; 132: 727-40.
9. Bork P, Beckmann G. The CUB domain. A widespread module in developmentally regulated protein. J Mol Biol 1993; 231: 539-45.
10. Miyazawa Y, Uekita T, Hiraoka N et al. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res 2010; 70: 5136-46.
11. Uekita T, Tanaka M, Takigahira M et al. CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma. Am J Pathol 2008; 172: 1729-39.
12. Bühring HJ, Kuçi S, Conze T et al. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and non hematopoietic origin. Stem Cells 2004; 22: 334-43.
13. Conze T, Lammers R, Kuci S et al. CDCP1 is a novel marker for hematopoietic stem cells. Ann NY Acad Sci 2004; 996: 222-6.
14. Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM, Hynes RO. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci USA 2011; 108: 1379-84.
15. Awakura Y, Nakamura E, Takahashi T et al. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma. J Cancer Res Clin Oncol 2008; 134: 1363-9.
16. Ikeda JI, Morii E, Kimura H et al. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells. J Pathol 2006; 210: 75-84.
17. Kimura H, Morii E, Ikeda JI et al. Role of DNA methylation for expression of novel stem cell marker CDCP1 in hematopoietic cells. Leukemia 2006; 20: 1551-6.
18. Ikeda J, Oda T, Inoue M et al. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung. Cancer Sci 2009; 100: 429-33.
19. Mamat S, Ikeda J, Enomoto T et al. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma. Oncol Rep 2010; 23: 1221-7.
20. Razorenova OV, Finger EC, Colavitti R et al. VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration. Proc Natl Acad Sci USA 2011; 108: 1931-6.
21. Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov 2003; 2: 803-11.
22. Le QT, Denko NC, Giaccia AJ. Hypoxic gene expression and metastasis. Cancer Metastasis Rev 2004; 23: 293-310.
23. Benes CH, Wu N, Elia AE, Dharia T, Cantley LC, Soltoff SP. The C2 domain of PKCδ is a phosphotyrosine binding domain. Cell 2005; 121: 271-80.
24. He Y, Wortmann A, Burke LJ et al. Proteolysis-induced n-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCδ. J Biol Chem 2010; 285: 26162-73.
25. Alvares SM, Dunn CA, Brown TA, Wayner EE, Carter WG. The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1. Biochim Biophys Acta 2008; 1780: 486-96.
26. Gu C, Limberg BJ, Whitaker GB et al. Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J Biol Chem 2002; 277: 18069-76.
27. André M, Le Caer JP, Greco C et al. Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS. Proteomics 2006; 6: 1437-49.
28. Burnham MR, Bruce-Staskal PJ, Harte MT et al. Regulation of c-Src activity and function by the adapter protein Cas. Mol Cell Biol 2000; 20: 5865-78.
29. Yadav SS, Miller WT. Cooperative activation of Src family kinases by SH3 and SH2 ligands. Cancer Lett 2007; 257: 116-23.
30. Deryugina EI, Conn EM, Wortmann A et al. Functional role of cell surface CUB domain-containing protein 1 in tumor dissemination. Mol Cancer Res 2009; 7: 1197-211.
31. Benes CH, Poulogiannis G, Cantley LC, Soltoff SP. The Src-associated protein CUB domain-containing protein-1 regulates adhesion and motility. Oncogene 2011; doi: [Epub ahead of print].
32. Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase C δ. Apoptosis 2003; 8: 19-27.
33. Wert MM, Palfrey HC. Divergence in the anti-apoptotic signaling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase Cδ. Biochem J 2000; 352: 175-82.
34. Clark AS, West KA, Blumberg PM, Dennis PA. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCδ promotes cellular survival and chemotherapeutic resistance. Cancer Res 2003; 63: 780-6.
35. Siva AC, Kirkland RE, Lin B et al. Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells. J Immunol Methods 2008; 330: 109-19.
36. Siva AC, Wild MA, Kirkland RE et al. Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model. Cancer Res 2008; 68: 3759-66.
37. Fukuchi K, Steiniger SC, Deryugina E et al. Inhibition of tumor metastasis: functional immune modulation of the CUB domain containing protein 1. Mol Pharm 2010; 7: 245-53.
38. Wong CH, Baehner FL, Spassov DS et al. Phosphorylation of the src epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers. Clin Cancer Res 2009; 15: 2311-22.
39. Spassov DS, Baehner FL, Wong CH, McDonough S, Moasser MM. The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation. Am J Pathol 2009; 174: 1756-65.